Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded to Sell at Zacks Investment Research – Riverton Roll
Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded to Sell at Zacks Investment Research Riverton Roll
Zacks Investment Research cut shares of Paratek Pharmaceuticals (NASDAQ:PRTK) from a hold rating to a sell rating in a report issued on Friday morning, …
Source: Investment New Feed